Publications
5600 Results
- Journal / Conference
- Leukemia & Lymphoma Nov;56(11):3031-3027
- Year
- 2015
- Research Committee(s)
- Leukemia
- PMID
- PMID25721902
- PMC
- PMC4688910
- Study Number(s)
- E2997
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
- Journal / Conference
- Journal of Thoracic Oncology Volume 10, Number 9, Supplement 2, September 2015; World Conference on Lung Cancer (WCLC), (September 6-9, 2015, Denver, CO), oral
- Year
- 2015
- Research Committee(s)
- Lung
- Study Number(s)
- S0819
A randomized, phase III study comparing carboplatin/paclitaxel or carboplatin/ paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC): SWOG S0819
- Journal / Conference
- Clinical Cancer Research May 15;21(10):2236-2243
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25979930
- PMC
- PMC4862209
- Study Number(s)
- S1400
Squamous cell lung cancer: from tumor genomics to cancer therapeutics
- Journal / Conference
- Clinical Cancer Research May 15;21(10):2213-2220
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25979927
- PMC
- PMC4505624
- Study Number(s)
- S1400
Lung cancer in the era of precision medicine
- Journal / Conference
- Lancet Oncology Aug;16(8):872-873
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26156654
- PMC
- Commentary not within scope of Public Access Policy
- Study Number(s)
- S1400
EGFR tyrosine kinase inhibitors in squamous cell lung cancer
- Journal / Conference
- Journal of Clinical Oncology Sep 10;33(26):2839-2840
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26215942
- PMC
- editorial not within scope of Public Access Policy
- Study Number(s)
- S1403
Patient-derived xenografts for investigation of acquired resistance in oncogene-driven cancers: building a better mousetrap
- Journal / Conference
- Journal of Thoracic Oncology Jul;10(7):1099-1106
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID26134227
- PMC
- PMC4493926
- Study Number(s)
- S0124
Multitrial evaluation of progression-free survival as a surrogate end point for overall survival in first-line extensive-stage small-cell lung cancer
- Journal / Conference
- Journal of Thoracic Oncology 2015 May;10(5):e36
- Year
- 2015
- Research Committee(s)
- Lung
- PMID
- PMID25898968
- PMC
- letter to editor not within scope of Public Access Policy
- Study Number(s)
- S0327, S0435, S0802
Reply to "diminishing role of platinum-sensitivity status in patients with small cell lung cancer"
- Journal / Conference
- Clinical Cancer Research 21(18):4048-4054
- Year
- 2015
- Research Committee(s)
- Genitourinary
- PMID
- PMID25967143
- PMC
- PMC4573791
- Study Number(s)
- CTSU/E2805
Effects of adjuvant sorafenib and sunitinib on cardiac function in renal cell carcinoma patients without overt metastases: results from ASSURE, ECOG 2805
- Journal / Conference
- Blood 126(23):908; American Society of Hematology Annual Meeting (Dec 5-8, 2015, Orlando, FL), oral;
- Year
- 2015
- Research Committee(s)
- Leukemia
- Study Number(s)
- S1117